Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Alessandra Pulvirenti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9542-9165; OpenAlex author ID A5075130652. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 6

  1. Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas. Co-author DOI 10.1038/s41467-026-69762-w↗
  2. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Co-author DOI 10.1016/j.ccell.2024.08.002↗
  3. Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups. Co-author DOI 10.3389/fonc.2024.1405612↗
  4. The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000005050↗
  5. Performance of the 7 th and 8 th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Ass… First author DOI 10.1097/sla.0000000000005313↗
  6. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model. Co-author DOI 10.1200/cci.21.00001↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Antonio Pea · 3 shared papers, 2023–2026 · strength 0.52
  2. Nigel Balfour Jamieson · 3 shared papers, 2023–2026 · strength 0.52
  3. Alessandro Zerbi · 3 shared papers, 2021–2024 · strength 0.40
  4. Stephan B. Dreyer · 2 shared papers, 2023–2026 · strength 0.35
  5. Colin J. McKay · 2 shared papers, 2023–2026 · strength 0.35
  6. Rita Teresa Lawlor · 2 shared papers, 2023–2026 · strength 0.35
  7. Aldo Scarpa · 2 shared papers, 2023–2026 · strength 0.35
  8. Roberto Salvia · 2 shared papers, 2023–2026 · strength 0.35
  9. Federica Marchesi · 2 shared papers, 2023–2024 · strength 0.30
  10. David Kuang-Fu Chang · 2 shared papers, 2023–2024 · strength 0.30
  11. Katharina Beyer · 2 shared papers, 2021–2023 · strength 0.24
  12. Carsten Kamphues · 2 shared papers, 2021–2023 · strength 0.24
  13. Georgios Antonios Margonis · 2 shared papers, 2021–2023 · strength 0.24
  14. Christopher Lee Wolfgang · 2 shared papers, 2021–2023 · strength 0.24
  15. Matthew John Weiss · 2 shared papers, 2021–2023 · strength 0.24
  16. Caitlin A. McIntyre · 2 shared papers, 2021–2024 · strength 0.24
  17. David K. Chang · 1 shared paper, 2026 · strength 0.22
  18. Fieke E. M. Froeling · 1 shared paper, 2026 · strength 0.22
  19. Claudio Luchini · 1 shared paper, 2026 · strength 0.22
  20. Giovanni Luigi Capretti · 1 shared paper, 2024 · strength 0.17
  21. Gennaro Nappo · 1 shared paper, 2024 · strength 0.17
  22. Marialuisa Barbagallo · 1 shared paper, 2024 · strength 0.17
  23. Nina Cortese · 1 shared paper, 2024 · strength 0.17
  24. Carlos F. Fernandez-del Castillo · 1 shared paper, 2023 · strength 0.15
  25. Peter J. Allen · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.